Bio-Rad Laboratories

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO.B and other ETFs, options, and stocks.

About BIO.B

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,700
Employees7,700
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,700
Employees7,700

BIO.B Key Statistics

Market cap
8.21B
Market cap8.21B
Price-Earnings ratio
-12.47
Price-Earnings ratio-12.47
Dividend yield
Dividend yield
Average volume
59.70
Average volume59.70
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$359.22
52 Week high$359.22
52 Week low
$225.29
52 Week low$225.29

BIO.B News

TipRanks 1d
Bio-Rad Laboratories’ Earnings Call Highlights Resilience

Bio-Rad Laboratories ((BIO)) has held its Q3 earnings call. Read on for the main highlights of the call. Elevate Your Investing Strategy: Take advantage of TipR...

Simply Wall St 1d
Bio-Rad Laboratories: Losses Widen 51% Annually, Undervalued Status Reinforces Turnaround Narrative

Bio-Rad Laboratories (BIO) posted another period of unprofitability, with net losses accelerating at a rate of 51% per year over the past five years. The compan...

Bio-Rad Laboratories: Losses Widen 51% Annually, Undervalued Status Reinforces Turnaround Narrative
Nasdaq 2d
Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday

Key Points The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but gro...

Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday

Analyst ratings

57%

of 7 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

More BIO.B News

TipRanks 2d
Bio-Rad Laboratories Reports Stable Q3 2025 Results

Bio-Rad Laboratories ( (BIO) ) has released its Q3 earnings. Here is a breakdown of the information Bio-Rad Laboratories presented to its investors. Elevate Yo...

Seeking Alpha 2d
Bio-Rad outlines flat to 1% currency-neutral revenue growth for 2025 while expanding ddPCR partnerships

Earnings Call Insights Bio-Rad outlines flat to 1% currency-neutral revenue growth for 2025 while expanding ddPCR partnerships Oct. 29, 2025 7:57 PM ET Bio-Rad...

Bio-Rad outlines flat to 1% currency-neutral revenue growth for 2025 while expanding ddPCR partnerships
TipRanks 3d
Bio-Rad Reports Q3 2025 Financial Results Amid Challenges

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own BIO.B. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.